REFERENCES
- Keichou N, Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am J Respir Med 2002; 1: 119–31.
- Iino Y, Toriyama M, Kudo K, et al. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl 1992; 157: 1620.
- Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998; 351: 420.
- Pirzada OM, Taylor CJ. Long term macrolide antibiotics improve pulmonary function in cystic fibrosis. Pediatr Pulmonol Suppl 1999; 19: 283.
- Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670–3.
- Shimane T, Asano K, Suzuki M, Hisamitsu T, Suzaki H. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro. Mediators Inflamm 2001; 10: 323–32.
- Muranaka H, Suga M, Sato K, et al. Superoxide scavenging activity of erythromycin-iron complex. Biochem Biophys Res Commun 1997; 232: 183–7.
- Tayler BS, Geller DA. Regulation of the inducible nitric oxide synthase (iNOS) gene. In: Salvemini D, Billiar TR, Vodovotz Y, eds. Nitric oxide and inflammation. Basle, Switzerland: Birkhauser Verlag, 2001: 1–27.
- Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxinitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87: 1620–4.
- Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42.
- Lundberg JON, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nature Med 1995; 1: 370–3.
- Zoritch B. Nitric oxide and asthma. Arch Dis Child 1995; 72: 259.
- Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxinitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250–4.
- Jordana M, Schulman J, McSharry C, et al. Heterogenous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1987; 137: 579–84.
- Tse WW, Williams J, Pall A, et al. Antineutrophil cytoplasm antibody-induced neutrophil nitric oxide production is nitric oxide synthase independent. Kidney Int 2002; 59: 593–600.
- Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002; 110: 349–56.
- Cuzzocre S. Role of nitric oxide and reactive oxygen species in arthritis. In: Salvemini D, Billiar TR, Vodovotz Y, eds. Nitric oxide and inflammation. Basle, Switzerland: Birkhauser Verlag, 2001: 145–60.
- Ferdinandy P, Schulz R. Roles of nitric oxide, superoxide, and peroxinitrite in myocardial ischemia-reperfusion injury and ischemic preconditioning. In: Salvemini D, Billiar TR, Vodovotz Y, eds. Nitric oxide and inflammation. Basle, Switzerland: Birkhauser Verlag, 2001: 191–206.
- Yermilov V, Rubio J, Ohshima H. Formation of 8- nitroguanine in DNA treated with peroxinitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett 1995; 376: 207–10.
- Levert H, Gressier B, Brunt C, et al. Time and concentration dependent influence of dirithromycin on neutrophil oxidative burst. J Antibiot (Tokyo) 1999; 52: 127–33.
- Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000; 292: 156–63.
- Mizoguchi H, Ogawa Y, Kanatsu K, et al. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol 2001; 16:111–29.
- Kunikata T, Miyazawa T, Kanatsu K, Kato S, Takeuchi K. Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in rats. Jpn J Pharmacol 2002; 88: 45–54.